Eli Lilly and Company (TSX:LLY)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Baqsimi Revenue	-	-	29.10M
Basaglar Revenue	638.00M	626.00M	676.90M
Humalog Revenue	1.97B	2.17B	2.32B
Humulin Revenue	657.00M	705.00M	917.10M
Jardiance Revenue	4.69B	3.43B	3.34B
Mounjaro Revenue	36.74B	22.97B	11.54B
Trajenta Revenue	266.00M	318.00M	353.90M
Trulicity Revenue	4.08B	4.28B	5.25B
Zepbound Injectable Revenue	18.70B	13.54B	4.93B
Other Cardiometabolic Health Revenue	344.00M	189.00M	187.90M
Cardiometabolic Health Revenue	68.37B	48.22B	29.52B
Oncology Revenue	10.05B	9.38B	8.75B
Immunology Revenue	5.60B	5.25B	4.39B
Neuroscience Revenue	1.72B	1.39B	1.47B
Other Product Revenue	738.00M	944.00M	903.00M
Revenue (Other)	-18.70B	-13.54B	-4.93B
Revenue (Total)	86.46B	65.18B	45.04B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
US Revenue	54.55B	43.48B	30.38B
Europe Revenue	15.32B	11.56B	6.92B
Japan Revenue	2.50B	2.13B	1.81B
China Revenue	3.06B	1.95B	1.66B
Other Foreign Countries Revenue	11.04B	6.06B	4.27B
Revenue (Other)	1.00M	-	400.00K
Revenue (Total)	86.46B	65.18B	45.04B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Revenue Change due to Price	-6.00%	5.00%
Revenue Change due to Volume	50.00%	27.00%
Revenue Change due to FX	1.00%	-

Data Source: Fiscal.ai Last updated: Sep 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error